site logo

FDA staff take neutral stance on Moderna, J&J boosters ahead of two-day meeting

Agency scientists emphasized both vaccines still offer strong protection against severe COVID-19, but acknowledged potential for added benefit with another dose.

Sarah Silbiger via Getty Images